Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

4317studies shown

Showing 3,337-3,348 of 4,317

RecruitingNCT07216872

Deep magnetic brain stimulation for heavy drinking

About this title

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

Read the official source — NCT07216872

Official study title

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With Alcohol Use Disorder (AUD)

Multiple locations, including Tuscaloosa

AddictionDevice studyAges 18–86

Countries: United States, Israel, Sweden
Sponsor: Brainsway

View study

RecruitingNCT07406945

Safety and outcomes of SpydrBlade Flex during endoscopic achalasia treatment

About this title

Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM

Read the official source — NCT07406945

Official study title

Safety and Efficacy of the Novel SpydrBlade Flex With Radiofrequency and Microwave Ablation Flexible Bipolar for Per-Oral Endoscopic Myotomy in Patients With Achalasia: A Multicenter Prospective Study

Multiple locations, including Guayaquil

BipolarityDevice studyAges 18+

Countries: Ecuador, China
Sponsor: Chinese University of Hong Kong

View study

RecruitingNCT05184335

Brilaroxazine or placebo for schizophrenia: short- and long-term study

About this title

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Read the official source — NCT05184335

What is this study about?

This study evaluates the safety and effectiveness of Brilaroxazine for people with schizophrenia.

Multiple locations, including Phoenix

SchizophreniaMedication studyAges 18–65

Countries: United States
Sponsor: Reviva Pharmaceuticals

View study

RecruitingNCT05269459

Cannabidiol or placebo for PTSD symptoms in adults

About this title

Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults

Read the official source — NCT05269459

What is this study about?

Researchers are comparing Cannabidiol Administered as Nantheia ATL5 and placebo, tracking side effects to assess safety in adults with PTSD.

In Omaha

PTSDMedication studyAges 21–65

Countries: United States
Sponsor: University of Nebraska

View study

RecruitingNCT07499440

HB-1 for post-traumatic stress symptoms

About this title

Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

Read the official source — NCT07499440

What is this study about?

Researchers are comparing HB-1 and placebo, tracking side effects to assess safety in people with PTSD.

Multiple locations, including Deakin

PTSDMedication studyAges 18–65

Countries: Australia
Sponsor: HB BioTech, LLC

View study

RecruitingNCT06611592

Pramipexole added to antidepressants for treatment-resistant OCD

About this title

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)

Read the official source — NCT06611592

What is this study about?

Researchers are comparing Pramipexole 0.088mg/tid, Pramipexole 0.18 mg/tid and Pramipexole 0.35 mg/tid to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.

In Braga

OCDMedication studyAges 18–64

Countries: Portugal
Sponsor: Clinical Academic Center (2CA-Braga)

View study

RecruitingNCT07684976

MRI-guided focused ultrasound for substance use: safety and feasibility

About this title

Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD)

Read the official source — NCT07684976

Official study title

Assessment of Safety and Feasibility of Focused Ultrasound (FUS) Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Substance Use Disorder (SUD)

In Toronto

AddictionDevice studyAges 18–70

Countries: Canada
Sponsor: Sunnybrook Health Sciences Centre

View study

RecruitingNCT07269873

Safety of a long-acting naltrexone implant with or without bupropion

About this title

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

Read the official source — NCT07269873

Official study title

A Sequential Dose Cohort Pharmacokinetic and Safety Study of Implantable Long-Acting Naltrexone Subcutaneous Pellets With or Without Bupropion Compared to Naltrexone IM Injection (Vivitrol®) in Healthy Normal Volunteers

In Miami

AddictionMedication studyAges 18–65

Countries: United States
Sponsor: BioCorRx Pharmaceuticals Inc

View study

RecruitingNCT05648591

One-year iloperidone safety study in adolescents with schizophrenia or bipolarity type I

About this title

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Read the official source — NCT05648591

Official study title

Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder

Multiple locations, including Dothan

Schizophrenia, BipolarityMedication studyAges 12–17

Countries: United States
Sponsor: Vanda Pharmaceuticals

View study

RecruitingNCT06229210

26-week safety study of lumateperone in children and adolescents

About this title

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Read the official source — NCT06229210

Official study title

An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder

Multiple locations, including Phoenix

Bipolarity, SchizophreniaMedication studyAges 5–17

Countries: United States, Colombia, Serbia
Sponsor: Intra-Cellular Therapies, Inc.

View study

RecruitingNCT06465381

Safety planning or CBT for suicide prevention in secondary schools in Mozambique

About this title

Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique

Read the official source — NCT06465381

Official study title

Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique: A Hybrid Effectiveness/Implementation Cluster Randomized Trial

Multiple locations, including Beira

SuicidalityBehavioural study

Countries: Mozambique
Sponsor: University of Washington

View study

RecruitingNCT07469917

Safety planning to prevent suicide in Swedish healthcare

About this title

Safety Planning Intervention in Swedish Healthcare: A Multisite Study for Suicide Prevention

Read the official source — NCT07469917

Official study title

Safety Planning Intervention in Swedish Healthcare: A Multisite Study for Suicide Prevention

Multiple locations, including Lund

SuicidalityBehavioural studyAges 18+

Countries: Sweden
Sponsor: Region Skane

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.